PTK2 and cancer: GSEA results for 15 cancers are shown in Figure S3 A-O, identifying common enrichment pathways including SRP-dependent co-translational protein targeting to membranes, MET activates PTK2 signaling, ribosome-related processes, and ECM receptor interactions.